The use of antiretroviral drugs (ARVs) in microbicides and the potential for the development of drug-resistant Strains of HIV: a consensus statement by IPM and the executive committee of the IPM scientific advisory board
The use of antiretroviral drugs (ARVs) in microbicides and the potential for the development of drug-resistant Strains of HIV: a consensus statement by IPM and the executive committee of the IPM scientific advisory board
- International Partnership for Microbicides 2008
- 6p.
Offers a comprehensive assessment of the balance of potential risks and benefits of using antiretroviral drugs to prevent HIV transmission is a priority for those involved in HIV prevention research and examines the background and structure on issues specific to vaginal microbicides. Examines the implications of drug resistance for the therapeutic outcome on HIV- treatment and the concerns regarding a microbicides potential impact on HIV drug resistance.
Antiretroviral Agents|Acquired Immune Deficiency Syndrome Virus|HIV Prevention|Anti-Infective Agents
ART WC 503.I66 2008
Offers a comprehensive assessment of the balance of potential risks and benefits of using antiretroviral drugs to prevent HIV transmission is a priority for those involved in HIV prevention research and examines the background and structure on issues specific to vaginal microbicides. Examines the implications of drug resistance for the therapeutic outcome on HIV- treatment and the concerns regarding a microbicides potential impact on HIV drug resistance.
Antiretroviral Agents|Acquired Immune Deficiency Syndrome Virus|HIV Prevention|Anti-Infective Agents
ART WC 503.I66 2008